Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the complete record of transactions filed by Hagen Brett R, Directeur Comptable. Director active across 2 companies, notably Allovir, Inc.. In total, 42 reports have been recorded. Breakdown: 0 buy · 38 sells. Total volume traded: €167k. Activity tracked since 20 January 2022. The latest transaction was disclosed on 20 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hagen Brett R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
28.335 títulos@ 0,7354 US$11.8% de su flujoCommon StockSEC:0000950170-24-000428:0
25 de 42 declaraciones
About Hagen Brett R
Hagen Brett R is Directeur Comptable. He has filed 42 disclosures in total, and in the sampled recent disclosures they are all sales, totaling EUR 166985 between 2022-01-24 and 2026-03-23. The companies mentioned in these disclosures are Allovir, Inc. and Kalaris Therapeutics, Inc.